治疗哮喘，包括难治性哮喘;我们作为制药公司的挑战

Proceedings for Annual Meeting of The Japanese Pharmacological Society Pub Date : 2022-01-01 DOI:10.1254/jpssuppl.95.0_2-s27-1

Ishii Takeo

{"title":"治疗哮喘，包括难治性哮喘;我们作为制药公司的挑战","authors":"Ishii Takeo","doi":"10.1254/jpssuppl.95.0_2-s27-1","DOIUrl":null,"url":null,"abstract":"Severe asthma, a part of difficult-to-treat asthma, represents a poorly controlled asthma despite maximally optimized treatment and its adherence. Uncontrolled asthma is judged by poor symptom control, frequent exacerbations requiring oral corticosteroids (OCS), or severe exacerbations requiring hospitalization. It is considered to be 5 percent or less of all asthmatics (GINA 2019).","PeriodicalId":20464,"journal":{"name":"Proceedings for Annual Meeting of The Japanese Pharmacological Society","volume":"74 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Treatment of asthma including intractable one; our challenge as a pharma and beyond\",\"authors\":\"Ishii Takeo\",\"doi\":\"10.1254/jpssuppl.95.0_2-s27-1\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Severe asthma, a part of difficult-to-treat asthma, represents a poorly controlled asthma despite maximally optimized treatment and its adherence. Uncontrolled asthma is judged by poor symptom control, frequent exacerbations requiring oral corticosteroids (OCS), or severe exacerbations requiring hospitalization. It is considered to be 5 percent or less of all asthmatics (GINA 2019).\",\"PeriodicalId\":20464,\"journal\":{\"name\":\"Proceedings for Annual Meeting of The Japanese Pharmacological Society\",\"volume\":\"74 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Proceedings for Annual Meeting of The Japanese Pharmacological Society\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1254/jpssuppl.95.0_2-s27-1\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Proceedings for Annual Meeting of The Japanese Pharmacological Society","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1254/jpssuppl.95.0_2-s27-1","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

摘要

重度哮喘是难治性哮喘的一部分，是一种控制不良的哮喘，尽管有最大限度的优化治疗和坚持治疗。不受控制的哮喘可通过症状控制不良、频繁发作需要口服皮质类固醇(OCS)或严重发作需要住院来判断。它被认为占所有哮喘患者的5%或更少(GINA 2019)。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Treatment of asthma including intractable one; our challenge as a pharma and beyond

Severe asthma, a part of difficult-to-treat asthma, represents a poorly controlled asthma despite maximally optimized treatment and its adherence. Uncontrolled asthma is judged by poor symptom control, frequent exacerbations requiring oral corticosteroids (OCS), or severe exacerbations requiring hospitalization. It is considered to be 5 percent or less of all asthmatics (GINA 2019).

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Proceedings for Annual Meeting of The Japanese Pharmacological Society

自引率

0.00%

发文量